Associated Papers
Could plasma based therapies still be considered in selected cases with atypical hemolytic uremic syndrome?
Özlü SG et al.
The Turkish Journal of Pediatrics, 2021
Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
Osborne AJ et al.
Journal of Immunology (baltimore, Md. : 1950), 2018
Select a paper to view details